Toronto - Delayed Quote CAD

Extendicare Inc. (EXE.TO)

Compare
10.14 +0.13 (+1.30%)
At close: November 15 at 4:00 p.m. EST
Loading Chart for EXE.TO
DELL
  • Previous Close 10.01
  • Open 9.99
  • Bid 10.12 x --
  • Ask 10.13 x --
  • Day's Range 9.99 - 10.20
  • 52 Week Range 6.45 - 10.43
  • Volume 154,705
  • Avg. Volume 160,141
  • Market Cap (intraday) 846.355M
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) 13.89
  • EPS (TTM) 0.73
  • Earnings Date Nov 12, 2024
  • Forward Dividend & Yield 0.48 (5.06%)
  • Ex-Dividend Date Oct 31, 2024
  • 1y Target Est 10.50

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

www.extendicare.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Care Facilities

Industry

Recent News: EXE.TO

View More

Performance Overview: EXE.TO

Trailing total returns as of 2024-11-15, which may include dividends or other distributions. Benchmark is

.

YTD Return

EXE.TO
46.64%
S&P/TSX Composite index
18.76%

1-Year Return

EXE.TO
67.64%
S&P/TSX Composite index
24.31%

3-Year Return

EXE.TO
69.87%
S&P/TSX Composite index
14.34%

5-Year Return

EXE.TO
68.82%
S&P/TSX Composite index
46.66%

Compare To: EXE.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EXE.TO

View More

Valuation Measures

As of 2024-11-15
  • Market Cap

    846.36M

  • Enterprise Value

    1.01B

  • Trailing P/E

    13.89

  • Forward P/E

    16.61

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.70

  • Price/Book (mrq)

    7.44

  • Enterprise Value/Revenue

    0.71

  • Enterprise Value/EBITDA

    7.24

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.28%

  • Return on Assets (ttm)

    7.16%

  • Return on Equity (ttm)

    60.00%

  • Revenue (ttm)

    1.39B

  • Net Income Avi to Common (ttm)

    59.44M

  • Diluted EPS (ttm)

    0.73

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    136.4M

  • Total Debt/Equity (mrq)

    305.80%

  • Levered Free Cash Flow (ttm)

    1.13M

Research Analysis: EXE.TO

View More

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

9.50 Low
10.50 Average
10.14 Current
11.50 High
 

People Also Watch